{"filing":{"accession_number":"0001193125-26-294837","cik":"0001177648","ticker":"ENTA","company_name":"ENANTA PHARMACEUTICALS INC","form":"8-K","filing_date":"2026-07-02","report_date":null,"primary_document":"d123412d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1177648/000119312526294837/d123412d8k.htm"},"events":[{"id":15959,"run_id":14234,"accession_number":"0001193125-26-294837","anchor_item_number":"1.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"Enanta Pharmaceuticals entered into an Open Market Sale Agreement with Jefferies LLC authorizing the sale of up to $75 million in common stock through an at-the-market (ATM) offering. This is a dilutive equity issuance that would materially affect existing shareholders through potential dilution and is a significant capital-raising event for the company.","company_name":"ENANTA PHARMACEUTICALS INC","ticker":"ENTA","filing_date":"2026-07-02","form":"8-K","submitted_at":null,"items":[{"id":13892,"accession_number":"0001193125-26-294837","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Enanta Pharmaceuticals entered into an Open Market Sale Agreement with Jefferies LLC authorizing the sale of up to $75 million in common stock through an at-the-market (ATM) offering. This is a dilutive equity issuance that would materially affect existing shareholders through potential dilution and is a significant capital-raising event for the company.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-02T20:57:40.847066+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":13892,"accession_number":"0001193125-26-294837","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Enanta Pharmaceuticals entered into an Open Market Sale Agreement with Jefferies LLC authorizing the sale of up to $75 million in common stock through an at-the-market (ATM) offering. This is a dilutive equity issuance that would materially affect existing shareholders through potential dilution and is a significant capital-raising event for the company.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-02T20:57:40.847066+00:00","company_name":"ENANTA PHARMACEUTICALS INC","ticker":"ENTA","filing_date":"2026-07-02"}]}